CONGLETON JON (Chief Executive Officer) sold 10.9% of their position (75K shares) of MINERALYS THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.96M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/30/2026ACC: 0001933414-26-000096
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-75K
Net shares
Net seller
$1.96M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
75K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−58K
Price / share
$25.94
Trade value
$1.50M
% of position
8.4%
6/30/2026
689.32K→631.32K
Common Stock
Direct
Shares
−17K
Price / share
$26.82
Trade value
$455.90K
% of position
2.7%
6/30/2026
631.32K→614.32K
Total
Net shares
−75K
Net value
-$1.96M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2026 | S · Sale | −58K | $25.94 | $1.50M | 8.4% | 689.32K | 631.32K |
| Common Stock Direct | 6/30/2026 | S · Sale | −17K | $26.82 | $455.90K | 2.7% | 631.32K | 614.32K |
| Total | −75K | -$1.96M | ||||||
Derivative Transactions0
No derivative transactions reported